KAYLA BREEDEN: Open Payments
NPI 1336765411 · DICKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 62 payments from 10 companies in 2025. Trend: 2023 $962 · 2024 $1,475 · 2025 $1,375
Food & beverage: $1,375
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $264 |
| E.R. Squibb & Sons, L.L.C. | 10 | $231 |
| Neurocrine BioSciences, Inc. | 8 | $201 |
| Janssen Pharmaceuticals, Inc | 10 | $190 |
| Teva Pharmaceuticals USA, Inc. | 8 | $135 |
| Axsome Therapeutics, Inc. | 3 | $92 |
| ABBVIE INC. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: ARISTADA, COBENFY, INGREZZA, INVEGA SUSTENNA, Auvelity, VRAYLAR, UZEDY, CAPLYTA.
Industry payments across TN — which companies pay providers there.
